Industry
Enterprise Ireland Funding Programmes 2026: The Complete Founder’s Guide to Grants, Pre-Seed (PSSF), iHPSU & Founder Visas
Master Enterprise Ireland's funding ecosystem: from Pre-Seed Start Fund (€50k-€100k) and Innovative HPSU Fund (€1.2M) to R&D, Green, and Digitalisation vouchers. Includes step-by-step application advice, readiness timelines, and non-EU founder visa rules.
Industry
The €8.5 Billion Defense: Dutch Innovative Pharma Fights Back Against Cost-Control Policies
The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Regulatory Affairs
The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories
An in-depth commercial analysis of the UK-India Comprehensive Economic and Trade Agreement (CETA), exploring its transformative impact on bilateral pharmaceutical manufacturing, active pharmaceutical ingredient (API) supply chains, and consumer medicine pricing.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Regulatory Affairs
Transatlantic Tariff Siege: EU Pushes US for €150B Exemption List to Protect MedTech and Spirits
As the Turnberry Deal’s 15% tariff baseline takes hold, Brussels has formally requested carve-outs for €150 billion worth of European goods. The stakes are exceptionally high for Ireland’s €13B medical technology industry, where critical components face severe transatlantic margin pressures.
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
Biotechnology
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.
Biotechnology
Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips
Dublin-based Pilot Photonics receives up to €10.4 million in EIC Accelerator funding to scale high-volume manufacturing of its patented photonic integrated circuits (PICs) for AI data centres, satellite transceivers, and 6G networks.
Industry
Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare
Intel has announced a massive €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland to expand semiconductor manufacturing capacity, driven by global demand for AI and high-performance computing.
Biotechnology
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
MGS Mfg. Group completes a major 115,000 sq ft expansion of its Leixlip, Ireland facility, boosting ISO Class 7 and 8 cleanroom capacity, advanced automation, and controlled "whiteroom" environments to meet surging European medical device and pharmaceutical demands.
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.